Jan 12, 2026 07:03AM
Jan 12, 2026 07:00AM
Nov 12, 2025 04:01PM
Oct 6, 2025 07:00AM
Oct 6, 2025 07:00AM
Aug 12, 2025 04:01PM
Jun 10, 2025 06:04AM Lyra Therapeutics (LYRA) PT Raised to $16 at H.C. Wainwright
Jun 2, 2025 04:32PM
Jun 2, 2025 10:25AM
Jun 2, 2025 07:01AM
Jun 2, 2025 07:00AM
Mar 13, 2025 04:01PM
May 21, 2024 09:14AM
May 21, 2024 09:14AM Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital
May 6, 2024 07:59AM
May 6, 2024 07:59AM
Apr 30, 2024 04:04PM
Mar 21, 2024 04:01PM
Nov 7, 2023 04:01PM
Oct 16, 2023 07:00AM
Sep 12, 2023 07:00AM Lyra Therapeutics (LYRA) Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220
Sep 12, 2023 07:00AM
Aug 29, 2023 07:00AM
Aug 8, 2023 04:01PM
Jun 2, 2023 04:01PM
Jun 1, 2023 07:29AM
May 12, 2023 07:00AM
Apr 25, 2023 07:59AM Lyra Therapeutics (LYRA) Restarts Phase 3 ENLIGHTEN II Clinical Trial of LYR-210
Apr 25, 2023 07:59AM
Mar 29, 2023 04:08PM
Mar 29, 2023 04:06PM
Feb 27, 2023 07:59AM
Feb 27, 2023 07:59AM
Feb 6, 2023 07:56AM
Jan 17, 2023 06:42PM Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 8, 2022 04:01PM
Sep 13, 2022 04:01PM
Sep 13, 2022 07:00AM
Sep 12, 2022 05:44AM
Sep 10, 2022 08:00AM
Sep 8, 2022 07:00AM
Sep 6, 2022 07:00AM Lyra Therapeutics to Present at the H.C. Wainwright AnnualGlobal Investment Conference 2022
Aug 29, 2022 07:00AM
Aug 9, 2022 07:00AM
Jul 5, 2022 07:02AM
Jul 5, 2022 07:00AM
Jul 5, 2022 07:00AM
Jun 17, 2022 04:01PM
May 26, 2022 07:00AM Lyra Therapeutics to Present at Upcoming Investor Conferences
May 10, 2022 07:00AM

322,088 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All